Pharma Deko Plc (NGX:PHARMDEKO)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
1.830
0.00 (0.00%)
At close: Dec 5, 2025

Pharma Deko Statistics

Total Valuation

Pharma Deko has a market cap or net worth of NGN 396.98 million. The enterprise value is 403.98 million.

Market Cap 396.98M
Enterprise Value 403.98M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

Pharma Deko has 216.93 million shares outstanding.

Current Share Class 216.93M
Shares Outstanding 216.93M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.85
PB Ratio 0.39
P/TBV Ratio 0.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.36
EV / Sales 0.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -12.11

Financial Position

The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.02.

Current Ratio 0.21
Quick Ratio 0.08
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.50
Interest Coverage -31.90

Financial Efficiency

Return on equity (ROE) is -25.54% and return on invested capital (ROIC) is -15.12%.

Return on Equity (ROE) -25.54%
Return on Assets (ROA) -7.79%
Return on Invested Capital (ROIC) -15.12%
Return on Capital Employed (ROCE) -26.53%
Revenue Per Employee 6.71M
Profits Per Employee -4.23M
Employee Count 70
Asset Turnover 0.21
Inventory Turnover 2.22

Taxes

In the past 12 months, Pharma Deko has paid 2.49 million in taxes.

Income Tax 2.49M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) -0.00
52-Week Price Change n/a
50-Day Moving Average 1.83
200-Day Moving Average 1.83
Relative Strength Index (RSI) 41.10
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Pharma Deko had revenue of NGN 469.58 million and -296.19 million in losses. Loss per share was -2.73.

Revenue 469.58M
Gross Profit 98.28M
Operating Income -284.77M
Pretax Income -293.70M
Net Income -296.19M
EBITDA -215.76M
EBIT -284.77M
Loss Per Share -2.73
Full Income Statement

Balance Sheet

The company has 9.79 million in cash and 16.78 million in debt, giving a net cash position of -6.99 million or -0.03 per share.

Cash & Cash Equivalents 9.79M
Total Debt 16.78M
Net Cash -6.99M
Net Cash Per Share -0.03
Equity (Book Value) 1.01B
Book Value Per Share 4.66
Working Capital -918.91M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.69 million and capital expenditures -4.66 million, giving a free cash flow of -33.36 million.

Operating Cash Flow -28.69M
Capital Expenditures -4.66M
Free Cash Flow -33.36M
FCF Per Share -0.15
Full Cash Flow Statement

Margins

Gross margin is 20.93%, with operating and profit margins of -60.64% and -63.07%.

Gross Margin 20.93%
Operating Margin -60.64%
Pretax Margin -62.54%
Profit Margin -63.07%
EBITDA Margin -45.95%
EBIT Margin -60.64%
FCF Margin n/a

Dividends & Yields

Pharma Deko does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -74.61%
FCF Yield -8.40%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2